Хайлтын үр дүнгүүд - Ravi Ramjeesingh
- 6-н 1 - 6 үр дүнгүүдийг харуулж байна
-
1
-
2
-
3
Barriers and Unequal Access to Timely Molecular Testing Results: Addressing the Inequities in Cancer Care Delays across Canada -н Stephanie Snow, Christine Brezden‐Masley, Michael D. Carter, Neesha C. Dhani, Cassandra Macaulay, Ravi Ramjeesingh, Michael J. Raphael, Monika Slovinec D’Angelo, Filomena Servidio-Italiano
Хэвлэсэн 2024Artigo -
4
Toward Timely and Equitable Advanced Biomarker Testing for Patients with Metastatic Cancer in Canada -н Brandon S. Sheffield, Shantanu Banerji, Allen Chankowsky, Shaan Dudani, Sharlene Gill, Zuzanna Gorski, Shaqil Kassam, Cassandra Macaulay, Mita Manna, Kirstin Perdrizet, Ravi Ramjeesingh, Monika Slovinec D’Angelo, Filomena Servidio-Italiano
Хэвлэсэн 2025Artigo -
5
LBA65 The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelim... -н D. J. Renouf, Jennifer J. Knox, Petr Kavan, Derek J. Jonker, Stephen Welch, Félix Couture, Frédéric Lemay, Mustapha Tehfé, Mohammed Harb, Nathalie Aucoin, Y-J. Ko, Patricia A. Tang, Ravi Ramjeesingh, Brandon M. Meyers, C. Kim, David F. Schaeffer, Jonathan M. Loree, Sharlene Gill, D. Tu, C. O'Callaghan
Хэвлэсэн 2020Artigo -
6
The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma -н Daniel J. Renouf, Jonathan M. Loree, Jennifer J. Knox, James T. Topham, Petr Kavan, Derek J. Jonker, Stephen Welch, Félix Couture, Frédéric Lemay, Mustapha Tehfé, Mohammed Harb, Nathalie Aucoin, Yoo‐Joung Ko, Patricia A. Tang, Ravi Ramjeesingh, Brandon M. Meyers, Christina Kim, Pan Du, Shidong Jia, David F. Schaeffer, Sharlene Gill, Dongsheng Tu, Chris J. O’Callaghan
Хэвлэсэн 2022Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Cancer
Internal medicine
Biology
Immunotherapy
Nivolumab
Oncology
Biochemistry
Bioinformatics
Cancer research
Durvalumab
Gemcitabine
Nab-paclitaxel
Pathology
Personalized medicine
Precision medicine
Adenocarcinoma
Atezolizumab
Bevacizumab
Biomarker
Cabozantinib
Cell
Cell adhesion
Cell adhesion molecule
Cell biology
Cell–cell interaction
Chemistry
Chemotherapy
Clinical endpoint
Clinical trial